Sectors
NNNN
Anbio Biotechnology
7.30
1 x 11.55
1 x 9.89
bid
ask
-
0.28
3.69%
1 @ 07:45 PM
7.38 +0.08 (1.10%)
| Ytd | -75.72% | |
| 1y | -83.79% |
7.08
day range
7.76
6.61
52 week range
51.33
| Open | 7.50 | Prev Close | 7.58 | Low | 7.08 | High | 7.76 | Mkt Cap | 320.41M |
| Vol | 279.21K | Avg Vol | 85.04K | EPS | 0.14 | P/E | 52.14 | Forward P/E | N/A |
| Beta | 5.40 | Short Ratio | 1.79 | Inst. Own | 4.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 10.59 | 200-d Avg | 22.90 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 43.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.77M | ||
| Cash and Equivalents (USD) | 7.77M | ||
| Investments | 4.13M | ||
| Investments Current | 4.13M | ||
| Trade and Non-Trade Receivables | 3.66M | ||
| Current Assets | 30.24M | ||
| Total Assets | 30.24M | ||
| Current Liabilities | 87.84K | ||
| Total Liabilities | 87.84K | ||
| Accumulated Retained Earnings (Deficit) | 23.58M | ||
| Shareholders Equity | 30.16M | ||
| Shareholders Equity (USD) | 30.16M | ||